GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Intrinsic Value: Projected FCF
中文

SANUWAVE Health (SANUWAVE Health) Intrinsic Value: Projected FCF

: $-0.12 (As of Today)
View and export this data going back to 2008. Start your Free Trial

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-23), SANUWAVE Health's Intrinsic Value: Projected FCF is $-0.12. The stock price of SANUWAVE Health is $0.0175. Therefore, SANUWAVE Health's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for SANUWAVE Health's Intrinsic Value: Projected FCF or its related term are showing as below:

SNWV's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.67
* Ranked among companies with meaningful Price-to-Projected-FCF only.

SANUWAVE Health Intrinsic Value: Projected FCF Historical Data

The historical data trend for SANUWAVE Health's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.19 -0.12 -0.20 -0.22 -0.12

SANUWAVE Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.25 -0.26 -0.18 -0.12

Competitive Comparison

For the Medical Devices subindustry, SANUWAVE Health's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SANUWAVE Health Price-to-Projected-FCF Distribution

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Price-to-Projected-FCF falls into.



SANUWAVE Health Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get SANUWAVE Health's Free Cash Flow(6 year avg) = $-8.37.

SANUWAVE Health's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)/0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-8.368+-43.178/0.8)/1124.090
=-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SANUWAVE Health  (OTCPK:SNWV) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

SANUWAVE Health's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0175/-0.11888621209604
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SANUWAVE Health Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


SANUWAVE Health (SANUWAVE Health) Business Description

Traded in Other Exchanges
N/A
Address
11495 Valley View Road, Eden Prairie, MN, USA, 30024
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Executives
Andrew Walko officer: President 11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
James E Besser director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p. director, other: Director by Deputization MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank director 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price director 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh officer: President 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii 10 percent owner 200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski director 99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc. director 3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom officer: Interim CFO 11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli director, officer: Chief Executive Officer 510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins officer: Chief Financial Officer 11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino director PO BOX 376, LOBBY L., ANN ARBOR MI 48105